A mum from Manchester who was told she only had months to live has now been given the breast cancer all-clear after a groundbreaking drug trial.
51-year-old Jasmin David from Fallowfield was a previously fit and healthy mother of two grown-up children, and was working as a clinical lead at a care home for the elderly, before she discovered that she had an aggressive triple negative form of breast cancer in November 2017 after finding a lump above the nipple.
Following her diagnosis, Jasmin then underwent six months of chemotherapy and a mastectomy in April 2018, followed by 15 cycles of radiotherapy.
These treatments successfully cleared her body of cancer, but sadly, back in October 2019, the cancer returned, and scans showed multiple lesions throughout her body meaning she had a poor prognosis.
Jasmin then discovered that the cancer had unfortunately spread to the lungs, lymph nodes, and chest bone, and was given the devastating news that she had less than a year to live.
ADVERTISEMENT
Two months later, and with no other options left, Jasmin was offered the opportunity to be part of research by participating in the first phase of a two-year groundbreaking clinical trial, which she accepted, and then in December 2019, began treatment at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at The Christie NHS Foundation Trust in Manchester.
Jasmin David is receiving groundbreaking treatment at The Christie NHS Foundation Trust in Manchester / Credit: The Christie NHS Foundation Trust
During the trial, Jasmin is given an experimental medicine combined with Atezolizumab – an immunotherapy drug administered intravenously – which she continues to have every three weeks.
ADVERTISEMENT
Jasmin says she feels “reborn” after beginning the treatment trial.
And she’s now showing no evidence of the disease, and enjoying life with her husband David and children Ryan and Riona.
“I was 15 months down the line after my initial cancer treatment and had almost forgotten about it, but then the cancer returned,” Jasmin explained.
“When I was offered the trial, I didn’t know if it would work for me, but I thought that at least I could do something to help others and use my body for the next generation. At first I had many horrible side effects including headaches and spiking temperatures, so I was in hospital over Christmas and quite poorly – but then thankfully, I started to respond well to the treatment.
"I take each day as a blessing in my life." Jasmin was diagnosed with cancer and given less than a year to live. But she's now been told she's clear of the disease after taking part in a clinical trial.
By June 2021, scans showed no measurable cancer cells in Jasmin’s body and she was then declared cancer free, but will still remain on treatment until December 2023.
Professor Fiona Thistlethwaite, medical oncologist and clinical director of Manchester CRF at The Christie – who is leading on the study in the UK – said: “We are really pleased that Jasmin has had such a good outcome, and at The Christie, we are continually testing new drugs and therapies to see if they can benefit more people.”
Salford Red Devils granted another adjournment over unpaid debts
Danny Jones
Salford Red Devils have been given one more adjournment and yet another stay of execution, being given another two weeks to find the money to cover their unpaid debts.
The local rugby league side, which has been wrapped in all manner of struggles both on and off-pitch over the past year or so, reportedly needs to pay around £700,000 to HMRC alone and still owes roughly £5 million in total to various creditors.
To no surprise, regular matchgoers, neutrals and even rivals alike have expressed their continued disappointment with the club, mainly at the lack of transparency and clarity from the organisation throughout this long, drawn-out process.
This is coming from a wire fan but no club deserves to be left in the dark even longer than they already have done it’s nothing but a disgrace to the sport of rugby those owners and the court should be ashamed of themselves.
Updating fans on social media, this is all the information they have communicated at this time: “Salford Red Devils can confirm that HMRC have granted the club a two-week adjournment, providing additional time in which to secure the necessary funds.
“We would like to reassure supporters that we are working tirelessly behind the scenes to ensure a positive resolution. Further updates will be shared as soon as possible.”
It’s worth noting that the current owners have reiterated that they inheited around £3m in existing debt before they took over the club, but assurances over their own investments have still come to nothing; meanwhile, with many still waiting on wages, players and staff alike have now left.
Having been propped up by loan players and emergency loans, the team is now closer to a skeleton crew than it is an outfit capable of competing in the premier division.
Either way, the outrage remains and is only growing stronger. One user wrote on X: “A good approach by them if they was legit would be to engage and bring in The 1873 to bridge the communication black hole (they created).
“The problem with that is if they did it would expose them for what they are… Extortionists using the club as a vehicle.”
More alarm bells were raised recently when assistant coach and Krisnan Inu – who was also director of the company set up to take over the business – withdrew himself from a key position behind the scenes.
Speaking of The 1873, the outspoken supporters trust took no time at all in issuing a response of their own, adding: “The judge presiding over today’s case has adjourned by 14 days. This adjournment has dragged the uncertainty on even longer.
“Every delay makes planning for 2026 harder and keeps the club stuck in limbo when it desperately needs clarity and direction.
“The fans, the players and the future all deserve better — The 1873.”
You can see the rest of their statement in full down below, but for now, what do you make of this seemingly neverending saga, Salfordians?
‘Christmas chaos’ on the cards as Manchester tram drivers vote on staging strike action next month
Emily Sergeant
There could be major disruption to festive travel in Greater Manchester next month, as hundreds of tram drivers are currently voting on whether to strike.
Almost 320 tram drivers are being balloted over working conditions and fears around fatigue.
The drivers – who are members of the union, Unite – all work for KeolisAmey Metrolink Limited at the Warwick Road South and Queens Road depots in Manchester – and they operate trams on all routes in Greater Manchester.
As it stands, the drivers’ shift patterns currently mean they have to work 450 hours over a 12-week period, which results in some having to work 50 hours on, followed by just two days off, then back into another 50-hour work pattern.
Drivers also have fewer rest days compared to all other operational departments, and this is said to be causing safety concerns around fatigue.
‘Christmas chaos’ is on the cards as Manchester tram drivers are currently voting on staging strike action next month / Credit: TfGM
Drivers say they concerned about operating heavy vehicles while exhausted and unable to have proper breaks, but after raising the issue with management, Unite has been told there is ‘no funding available’ to support any ‘meaningful’ improvements to working patterns.
Instead, management has asked drivers to start work earlier – which Unite says is only ‘adding insult to injury’.
The ballot is set to close on 11 November, and if drivers vote in favour of industrial action, strikes could then begin in late November, causing widespread cancellations and delays throughout the region during the busy festive shopping period – particularly coinciding with Manchester’s world-famous Christmas Markets, known for attracting millions of visitors to the city each year.
“Any strike action will cause a great deal of disruption but it is entirely the fault of Metrolink, which is not taking the issue of driver fatigue seriously,” commented Unite Regional Officer, Colin Hayden.